date: 2021-02-07T14:16:27Z
pdf:unmappedUnicodeCharsPerPage: 17
pdf:PDFVersion: 1.7
pdf:docinfo:title: Viability Assessment in Liver Transplantation?What Is the Impact of Dynamic Organ Preservation?
xmp:CreatorTool: LaTeX with hyperref
Keywords: viability testing; machine perfusion; mitochondria; liver transplantation
access_permission:modify_annotations: true
access_permission:can_print_degraded: true
subject: Based on the continuous increase of donor risk, with a majority of organs classified as marginal, quality assessment and prediction of liver function is of utmost importance. This is also caused by the notoriously lack of effective replacement of a failing liver by a device or intensive care treatment. While various parameters of liver function and injury are well-known from clinical practice, the majority of specific tests require prolonged diagnostic time and are more difficult to assess ex situ. In addition, viability assessment of procured organs needs time, because the development of the full picture of cellular injury and the initiation of repair processes depends on metabolic active tissue and reoxygenation with full blood over several hours or days. Measuring injury during cold storage preservation is therefore unlikely to predict the viability after transplantation. In contrast, dynamic organ preservation strategies offer a great opportunity to assess organs before implantation through analysis of recirculating perfusates, bile and perfused liver tissue. Accordingly, several parameters targeting hepatocyte or cholangiocyte function or metabolism have been recently suggested as potential viability tests before organ transplantation. We summarize here a current status of respective machine perfusion tests, and report their clinical relevance.
dc:creator: Rebecca Panconesi, Mauricio Flores Carvalho, Matteo Mueller, David Meierhofer, Philipp Dutkowski, Paolo Muiesan and Andrea Schlegel
dcterms:created: 2021-02-07T14:09:28Z
Last-Modified: 2021-02-07T14:16:27Z
dcterms:modified: 2021-02-07T14:16:27Z
dc:format: application/pdf; version=1.7
title: Viability Assessment in Liver Transplantation?What Is the Impact of Dynamic Organ Preservation?
Last-Save-Date: 2021-02-07T14:16:27Z
pdf:docinfo:creator_tool: LaTeX with hyperref
access_permission:fill_in_form: true
pdf:docinfo:keywords: viability testing; machine perfusion; mitochondria; liver transplantation
pdf:docinfo:modified: 2021-02-07T14:16:27Z
meta:save-date: 2021-02-07T14:16:27Z
pdf:encrypted: false
dc:title: Viability Assessment in Liver Transplantation?What Is the Impact of Dynamic Organ Preservation?
modified: 2021-02-07T14:16:27Z
cp:subject: Based on the continuous increase of donor risk, with a majority of organs classified as marginal, quality assessment and prediction of liver function is of utmost importance. This is also caused by the notoriously lack of effective replacement of a failing liver by a device or intensive care treatment. While various parameters of liver function and injury are well-known from clinical practice, the majority of specific tests require prolonged diagnostic time and are more difficult to assess ex situ. In addition, viability assessment of procured organs needs time, because the development of the full picture of cellular injury and the initiation of repair processes depends on metabolic active tissue and reoxygenation with full blood over several hours or days. Measuring injury during cold storage preservation is therefore unlikely to predict the viability after transplantation. In contrast, dynamic organ preservation strategies offer a great opportunity to assess organs before implantation through analysis of recirculating perfusates, bile and perfused liver tissue. Accordingly, several parameters targeting hepatocyte or cholangiocyte function or metabolism have been recently suggested as potential viability tests before organ transplantation. We summarize here a current status of respective machine perfusion tests, and report their clinical relevance.
pdf:docinfo:subject: Based on the continuous increase of donor risk, with a majority of organs classified as marginal, quality assessment and prediction of liver function is of utmost importance. This is also caused by the notoriously lack of effective replacement of a failing liver by a device or intensive care treatment. While various parameters of liver function and injury are well-known from clinical practice, the majority of specific tests require prolonged diagnostic time and are more difficult to assess ex situ. In addition, viability assessment of procured organs needs time, because the development of the full picture of cellular injury and the initiation of repair processes depends on metabolic active tissue and reoxygenation with full blood over several hours or days. Measuring injury during cold storage preservation is therefore unlikely to predict the viability after transplantation. In contrast, dynamic organ preservation strategies offer a great opportunity to assess organs before implantation through analysis of recirculating perfusates, bile and perfused liver tissue. Accordingly, several parameters targeting hepatocyte or cholangiocyte function or metabolism have been recently suggested as potential viability tests before organ transplantation. We summarize here a current status of respective machine perfusion tests, and report their clinical relevance.
Content-Type: application/pdf
pdf:docinfo:creator: Rebecca Panconesi, Mauricio Flores Carvalho, Matteo Mueller, David Meierhofer, Philipp Dutkowski, Paolo Muiesan and Andrea Schlegel
X-Parsed-By: org.apache.tika.parser.DefaultParser
creator: Rebecca Panconesi, Mauricio Flores Carvalho, Matteo Mueller, David Meierhofer, Philipp Dutkowski, Paolo Muiesan and Andrea Schlegel
meta:author: Rebecca Panconesi, Mauricio Flores Carvalho, Matteo Mueller, David Meierhofer, Philipp Dutkowski, Paolo Muiesan and Andrea Schlegel
dc:subject: viability testing; machine perfusion; mitochondria; liver transplantation
meta:creation-date: 2021-02-07T14:09:28Z
created: 2021-02-07T14:09:28Z
access_permission:extract_for_accessibility: true
access_permission:assemble_document: true
xmpTPg:NPages: 25
Creation-Date: 2021-02-07T14:09:28Z
pdf:charsPerPage: 4041
access_permission:extract_content: true
access_permission:can_print: true
meta:keyword: viability testing; machine perfusion; mitochondria; liver transplantation
Author: Rebecca Panconesi, Mauricio Flores Carvalho, Matteo Mueller, David Meierhofer, Philipp Dutkowski, Paolo Muiesan and Andrea Schlegel
producer: pdfTeX-1.40.21
access_permission:can_modify: true
pdf:docinfo:producer: pdfTeX-1.40.21
pdf:docinfo:created: 2021-02-07T14:09:28Z